Promising antimycotics for the treatment of invasive infections

Abstract

This paper provides a review of the largest studies (over the period of 2018 to 2023) of promising novel antimycotics and their possible role in the treatment of invasive mycoses, including infections caused by resistant Candida and Aspergillus isolates.

Keywords

• fosmanogepix
• ibrexafungerp
• olorofim
• opelconazole
• rezafungin
• invasive mycoses
• antimycotics